Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.67
-0.10 (-1.48%)
At close: Dec 1, 2025, 4:00 PM EST
6.65
-0.02 (-0.33%)
After-hours: Dec 1, 2025, 7:34 PM EST
Niagen Bioscience Employees
Niagen Bioscience had 104 employees as of December 31, 2024. The number of employees decreased by 2 or -1.89% compared to the previous year.
Employees
104
Change (1Y)
-2
Growth (1Y)
-1.89%
Revenue / Employee
$1,199,125
Profits / Employee
$196,433
Market Cap
534.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 104 | -2 | -1.89% |
| Dec 31, 2023 | 106 | -7 | -6.19% |
| Dec 31, 2022 | 113 | -2 | -1.74% |
| Dec 31, 2021 | 115 | 5 | 4.55% |
| Dec 31, 2020 | 110 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NAGE News
- 16 days ago - Niagen Bioscience: A Breakout Quarter That Now Faces Its Biggest Market Shift In Years - Seeking Alpha
- 18 days ago - Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside) - Business Wire
- 19 days ago - Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID - Business Wire
- 25 days ago - Niagen Bioscience Announces $10 Million Share Repurchase Program - Business Wire
- 27 days ago - Niagen Bioscience, Inc. (NAGE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook - Business Wire
- 5 weeks ago - Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - Business Wire
- 2 months ago - Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth - Business Wire